Prehospital thrombolysis: Beneficial effects of very early treatment on infarct size and left ventricular function
- 1 November 1993
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 22 (5) , 1304-1310
- https://doi.org/10.1016/0735-1097(93)90534-8
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Myocardial infarction triage and intervention project—Phase I: Patient characteristics and feasibility of prehospital initiation of thrombolytic therapyJournal of the American College of Cardiology, 1990
- Shoulo thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot studyJournal of the American College of Cardiology, 1990
- Prehospital use of APSAC: Results of a placebo-controlled studyThe American Journal of Cardiology, 1989
- A double blind placebo controlled study of early and late administration of recombinant tissue plasminogen activator in acute myocardial infarction.Heart, 1989
- Lessons from the European Cooperative recombinant tissue-type plasminogen activator (rt-PA) versus placebo trialJournal of the American College of Cardiology, 1988
- TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988
- Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986
- Prevention of Myocardial Damage in Acute Myocardial Ischemia by Early Treatment with Intravenous StreptokinaseNew England Journal of Medicine, 1985
- Intravenous short-term infusion of streptokinase in acute myocardial infarction.Circulation, 1983